Skip to main content
. 2017 Jan 31;15(1):109–117. doi: 10.5217/ir.2017.15.1.109

Table 2. Baseline Characteristics of the Study Population at Index Colonoscopy according to Follow-up.

Characteristic LRA group (n=486) HRA group (n=409)
Follow-up (n=221) No follow-up (n=265) P-value Follow-up (n=178) No follow-up (n=231) P-value
Clinical characteristics
 Age (yr) 56.1±9.4 56.5±12.2 0.649 57.3±9.1 60.4±9.0 0.003
 Male sex 156 (70.6) 159 (60.0) 0.015 122 (68.5) 156 (67.5) 0.829
 BMI (kg/m2) 24.8±3.1 24.2±3.2 0.064 24.9±3.1 24.0±3.4 0.011
 Smoker 92 (41.6) 76 (28.7) 0.003 78 (43.8) 97 (42.0) 0.208
 Family history of CRC 7 (3.2) 12 (4.5) 0.441 9 (5.1) 10 (4.3) 0.729
 Aspirin/NSAID user 29 (13.1) 24 (9.1) 0.152 17 (9.6) 14 (6.1) 0.186
Pathological characteristics
 Number 1.3±0.5 1.2±0.4 0.151 2.6±1.6 2.3±1.7 0.045
 Size (mm) 5.9±2.3 5.9±1.4 0.747 11.6±6.7 11.5±4.7 0.869
 Location (proximal) 123 (55.7) 112 (42.3) 0.008 88 (49.4) 114 (49.4) 0.197
 Shape (non-polypoid) 31 (14.0) 40 (15.1) 0.740 28 (15.7) 43 (18.6) 0.445
 Serrated polyp 33 (14.9) 44 (16.6) 0.603 33 (18.5) 44 (19.0) 0.896

Values are presented as mean±SD or number (%).

LRA, low-risk adenoma; HRA, high-risk adenoma; CRC, colorectal cancer.